Inmunotek S.L.: Hypersensitivity trials
The registry lists 15 Hypersensitivity studies with Inmunotek S.L. as lead sponsor. 9 are open to participants now and 0 have results posted.
Phase 2 3Phase 3 6No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Determination of Blomia Tropicalis Allergen Extract in Prick Test UnitsNot yet recruitingNCT07195929Not applicable
- Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.RecruitingNCT06790368
- Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom AllergyRecruitingNCT06782217
- Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen ExtractNot yet recruitingNCT05641272Phase 2/3
- Quercus Ilex and Quercus Robur Allergen Extracts StandardisationRecruitingNCT05532566Not applicable
- Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/RhinoconjunctivitisNot yet recruitingNCT05400811Phase 3
- Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.RecruitingNCT04898283Phase 3
- Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive PollenRecruitingNCT04891237Phase 3
- Efficacy and Safety Evaluation for the Treatment of Allergy Against MitesRecruitingNCT04435990Phase 3
- Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max ForteCompletedNCT07427576
- Phleum Pratense and Dactylis Glomerata Allergen Extracts StandardizationCompletedNCT06957496Not applicable
- Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.CompletedNCT05533385Not applicable
- Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/RhinoconjunctivitisTerminatedNCT04874714Phase 3
- Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite AllergyStatus unknownNCT02661854Phase 2
- Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen AllergyCompletedNCT02654223Phase 2